Aryavan Enterprise Ltd share price
You have to be logged in to add this to Watchlist.- ₹45.00(0.72%)January 12, 2026 15:13:48 PM IST
- NSE
- BSE
- Vol : 25.03 K (NSE + BSE)Last 20 day avg : 0
Aryavan Enterprise Ltd is trading 0.72% upper at Rs 45.00 as compared to its last closing price. Aryavan Enterprise Ltd has been trading in the price range of 45.49 & 41.00. Aryavan Enterprise Ltd has given 4.61% in this year & 2.06% in the last 5 days. The company posted a net profit of 0.52 Crores in its last quarter.Listed peers of Aryavan Enterprise Ltd include Torrent Pharmaceuticals (-0.37%), Divi's Laboratories (-1.89%), Dr Reddy's Laboratories (0.48%).The Mutual Fund holding in Aryavan Enterprise Ltd was at -% in . The MF holding has - from the last quarter. The FII holding in Aryavan Enterprise Ltd was at -% in . The FII holding has - from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Jan 12, 2026, 06:38 PM UTC
- BetaLow volatility-0.14Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Dividend YieldHigher than industry1.12Annual dividends as a percentage of the stock price.
- P/BLower than historical values1.04The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- PEG RatioIndicates undervaluation0.06The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- Debt To Equity-The debt-to-equity ratio, indicating a company's financial leverage.
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Torrent Pharmaceuticals | Bullish | 3,948.25 | -0.37 | 1,33,650.02 | 67.60 | 17.17 | 0.83 | 17.62 |
| Divi's Laboratories | Bullish | 6,491.90 | -1.89 | 1,72,403.39 | 77.35 | 11.34 | 0.47 | 0.01 |
| Dr Reddy's Laboratories | Bearish | 1,215.25 | 0.48 | 1,01,089.38 | 18.71 | 3.15 | 0.63 | 2.34 |
| Sun Pharmaceutical Industries | Neutral | 1,734.40 | 0.26 | 4,14,477.34 | 35.88 | 5.71 | 0.93 | 0.50 |
| Cipla | Bearish | 1,466.05 | -0.01 | 1,18,366.87 | 23.18 | 3.91 | 0.86 | 0.81 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-11-20 | Interim Dividend |
| 2025-11-14 | Quarterly Results |
| 2025-10-16 | Interim Dividend |
| 2025-08-13 | Quarterly Results |
| 2025-05-30 | Audited Results |
- IndustryBiotechnology & Drugs
- ISININE360S01012
- BSE Code539455
- NSE Code
- Management Info
Aryavan Enterprise Ltd is trading at 45.00 as on Mon Jan 12 2026 09:43:48. This is 0.72% upper as compared to its previous closing price of 44.68.
The market capitalization of Aryavan Enterprise Ltd is 31.82 Cr as on Mon Jan 12 2026 09:43:48.
The 52 wk high for Aryavan Enterprise Ltd is 63.70 whereas the 52 wk low is 31.57
Aryavan Enterprise Ltd can be analyzed on the following key metrics -
- TTM P/E: 17.28
- Sector P/E: -
- Dividend Yield: 1.12%
- D/E ratio: 0.01
Aryavan Enterprise Ltd reported a net profit of 1.35 Cr in 2025.